2.Transcription factor Forkhead-box A1 and breast cancer.
Chinese Journal of Pathology 2010;39(2):136-139
Animals
;
Antineoplastic Agents
;
therapeutic use
;
Breast Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
Cyclin-Dependent Kinase Inhibitor p27
;
Fenretinide
;
therapeutic use
;
Hepatocyte Nuclear Factor 3-alpha
;
genetics
;
metabolism
;
Humans
;
Intracellular Signaling Peptides and Proteins
;
metabolism
;
Prognosis
;
Receptors, Estrogen
;
metabolism
3.Molecular pathology of inflammatory breast cancer.
Chinese Journal of Pathology 2010;39(1):59-62
Cadherins
;
metabolism
;
Female
;
Gene Expression Profiling
;
Humans
;
Inflammatory Breast Neoplasms
;
genetics
;
metabolism
;
pathology
;
NF-kappa B
;
metabolism
;
Receptor, ErbB-2
;
metabolism
;
Receptor, Notch3
;
Receptors, CCR7
;
metabolism
;
Receptors, CXCR4
;
metabolism
;
Receptors, Notch
;
metabolism
5.MicroRNA and breast cancer-related hormone receptors.
Jing ZHANG ; Yun NIU ; Qi YU
Chinese Journal of Pathology 2011;40(3):212-214
6.A study of single-walled carbon nanotubes modified by organics of the phthalocyanine category
Zhonghui XU ; Haibo NIU ; Yun JIANG
Journal of Pharmaceutical Analysis 2008;20(3):193-197
Organics of the phthalocyanine category have very good nonlinear optical properties. The single-walled carbon nanotubes were modified by using the phenoxy phthalocyanine. Characterization analysis was made by means of the transmission electron microscope (TEM), ultraviolet visible absorptive spectra, fluorescent spectra and Raman spectra. Under the TEM, it was observed that the composite looked like sugarcoated haws. By comparing the ultraviolet visible absorptive spectra before and after absorption, it was disclosed that the spectral intensity and the intensity of the peaks in the fluorescent spectra dropped remarkably. This shows that the single-walled carbon nanotubes have absorbed a large number of phenoxy phthalocyanines. Raman analysis revealed that in the Raman spectra, the position of the main peaks of the single-walled carbon nanotubes after absorption moved in the direction of long waves. The analysis suggests that the movement of the Raman spectra results from the change in the state of the single-walled carbon nanotubes before and after absorption.
7.SCF protects the cortical neuron from apoptotic cell death in diabetic mice
Yun LUO ; Wenjing ZHU ; Fengnan NIU ; Yun XU
Chinese Journal of Nervous and Mental Diseases 2009;35(12):730-733
Objective To investigate the role of SCF on neuronal apoptosis induced by diabetes and its possible mechanism.Methods Twenty-seven male C57 mice were randomly divided into control group,diabetes group,and diabe-tes plus stem cell factor(SCF)group.The diabetic mice were induced by streptozotocin.TUNEL staining was used to assess neuronal apoptosis and western blot were used to detect the protein level of BCL-2,BAX,CASPASE 3 and P-ERK/ERK.Results Compared with the controls,the number of apoptotic neuron death and the protein levels of active CASPASE 3 were significantly increased in the cortex of diabetic mice.Treatment with SCF significantly reduced apoptotic neuron death and attenuated the increased in protein levels of active CASPASE 3 in the cortex of diabetic mice.The levels of BCL-2 and BAX were significantly increased in the diabetic animals compared to the controls.Treatment with SCF could significantly attenuated the increase in the expression of BAX but could not affect the level of BCL-2 in the cortex of diabetic mice.P-ERK was significantly decreased in the diabete group but not in dibete plus SCF group.Conclusions SCF can protect a-gainst diabete-induced apoptotic neuron death through increasing the phosphorylation of ERK and influencing the expression of BCL-2/BAX.
8.Recent advances in studies on in-situ and invasive ductal carcinoma.
Rong-ju ZHANG ; Yun NIU ; Yu-xia GAO
Chinese Journal of Pathology 2009;38(1):63-65
Aneuploidy
;
Breast Neoplasms
;
genetics
;
metabolism
;
pathology
;
Carcinoma in Situ
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Ductal, Breast
;
genetics
;
metabolism
;
pathology
;
Cell Movement
;
DNA Methylation
;
DNA, Neoplasm
;
genetics
;
Female
;
Humans
;
Membrane Proteins
;
metabolism
;
Neoplasm Invasiveness
9.Recent advances in PLK1 and breast cancer.
Zi-yu LIU ; Yun NIU ; Rong-ju ZHANG
Chinese Journal of Pathology 2011;40(6):427-429
Antineoplastic Agents
;
therapeutic use
;
BRCA2 Protein
;
metabolism
;
Breast Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Cell Cycle Proteins
;
metabolism
;
physiology
;
Centrosome
;
metabolism
;
Drug Screening Assays, Antitumor
;
Female
;
Humans
;
Microtubule-Associated Proteins
;
metabolism
;
Neoplasm Invasiveness
;
Nuclear Proteins
;
metabolism
;
Phosphorylation
;
Prognosis
;
Protein-Serine-Threonine Kinases
;
metabolism
;
physiology
;
Proto-Oncogene Proteins
;
metabolism
;
physiology
;
RNA, Small Interfering
;
pharmacology
;
Tumor Suppressor Protein p53
;
metabolism
10.Clinico pathologic characteristics and molecular phenotypes of young breast cancer patients and their clinical significance
Ying QIN ; Tongxian ZHANG ; Wei ZHANG ; Shuhua LV ; Yun NIU
Chinese Journal of Clinical Oncology 2014;46(4):231-236
Objective:To study the clinico-pathologic characteristics, molecular phenotypes, and prognosis of young breast can-cer patients. Methods:Data from 133 low-age (age≤30 years) young breast cancer patients and 117 young (31 years≤age≤35 years) breast cancer patients who underwent surgery between January 2002 and December 2009 were reviewed. Cases of the middle and old-age elderly (age>35 years) breast cancer patients during the corresponding period were randomly selected as matched controls. The clinico-pathologic characteristics, molecular phenotypes, and prognosis were retrospectively analyzed. Results:The low-age young and young breast cancer patients significantly differed from the elderly patients in terms of tumor size, lymph node metastasis, histological grading, molecular phenotype, and relapse (P<0.05). The low-age young patients are more vulnerable to have triple-negative breast can-cer, recurrence, and distant metastasis (P<0.001). Moreover, the low-age young patients have lower overall survival and disease-free survival than the other groups (P<0.05). Conclusion:Young breast cancer patients have poor prognosis compared with the elderly. Ear-ly screening and prompt treatment are necessary for young breast cancer patients.